Researchers iron out the link between serum ferritin and diabetes

September 10, 2012

Iron overload increases the risk for insulin resistance and type 2 diabetes; however, the exact mechanisms that link the two are unknown.

In today's issue of the , Donald McClain and colleagues at the University of Utah report that serum ferritin levels could predict the presence or absence of metabolic syndrome in humans and were inversely associated with the expression of adiponectin, a blood glucose-regulating protein produced by fat cells (adipocytes).

Treatment of adipocytes with iron decreased adiponectin levels, indicating that adipocytes play a central role in nutrient and iron detection. Further, reduction of serum ferritin levels in human patients increased insulin sensitivity and .

This study underscores the importance of adipocytes in metabolic diseases and points to iron reduction as a possible treatment for diabetes.

Explore further: Maternal glycemic status linked to epigenetic changes

More information: Adipocyte Iron Regulates Adiponectin and Insulin Sensitivity, Journal of Clinical Investigation, 2012. doi:10.1172/JCI44421

Related Stories

Maternal glycemic status linked to epigenetic changes

March 9, 2012
(HealthDay) -- Maternal glycemic status and adiponectin levels are linked to epigenetic changes in the adiponectin gene (ADIPOQ), according to a study published online March 6 in Diabetes.

21st century bloodletting reduces cardiovascular risk

May 29, 2012
It seems that while the practice of bloodletting throughout history had little or no effect on most diseases, and the practice was abandoned in the 19th century, new research published in BioMed Central's open access journal ...

Diabetes drug side effects traced to fat action

July 5, 2011
For better or worse, a popular class of anti-diabetic drugs does more than lower blood sugar. One known as rosiglitazone (trade name Avandia) has been in the spotlight for its possible link to increased cardiovascular events, ...

Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction

June 22, 2012
Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that involves the ineffective production ...

Recommended for you

Gene therapy improves immunity in babies with 'bubble boy' disease

December 9, 2017
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. ...

In lab research, scientists slow progression of a fatal form of muscular dystrophy

December 8, 2017
In a paper published in the Nature journal Scientific Reports, Saint Louis University (SLU) researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne ...

Double-blind study shows HIV vaccine not effective in viral suppression

December 7, 2017
(Medical Xpress)—A large team of researchers from the U.S. and Canada has conducted a randomized double-blind study of the effectiveness of an HIV vaccine and has found it to be ineffective in suppressing the virus. In ...

Time matters: Does our biological clock keep cancer at bay?

December 7, 2017
Our body has an internal biological or "circadian" clock, which cycles daily and is synchronized with solar time. New research done in mice suggests that it can help suppress cancer. The study, publishing 7 December in the ...

Novel harvesting method rapidly produces superior stem cells for transplantation

December 7, 2017
A new method of harvesting stem cells for bone marrow transplantation - developed by a team of investigators from the Massachusetts General Hospital (MGH) Cancer Center and the Harvard Stem Cell Institute - appears to accomplish ...

Inhibiting TOR boosts regenerative potential of adult tissues

December 7, 2017
Adult stem cells replenish dying cells and regenerate damaged tissues throughout our lifetime. We lose many of those stem cells, along with their regenerative capacity, as we age. Working in flies and mice, researchers at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.